English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

A previous study showed that single intracisternal administration of p-nitrotoluene into neonatal rats caused hyperactivity. To evaluate the neural risk assessment of p-nitrotoluene, it is crucial to test the potential of the chemical via environmental exposure route. In this study, we tested the hypothesis that oral exposure to p-nitrotoluene would exhibit the effects observed previously with direct instillation. Oral administration of 600 μg/day p-nitrotoluene into male Wistar rat pups, 5 days to 3 weeks of age, caused significant hyperactivity at 4-5 weeks of age. Treated rats were about 1.3 times active in the nocturnal phase than the vehicle-treated control rats (p < 0.05). The long-term effects of the chemical caused a large reduction in tyrosine hydroxylase (TH) immunoreactivity in the midbrain at 7 weeks of age, at which terminal deoxynucleotidyl transferase-mediated dUTP nick end-labelling-positive cells were detected. Immunohistochemical analysis of glial fibrillary acidic protein also revealed p-nitrotoluene-induced gliosis in the substantia nigra, suggesting neurodegeneration. Furthermore, neonatal p-nitrotoluene-induced lesion decreased the gene expression levels of dopamine transporter in adult rats. Thus, we conclude that p-nitrotoluene via oral exposure route caused rat hyperactivity, concomitant with gliosis and impairment of TH immunoreactivity, most likely due to degeneration of dopaminergic neurons.

fundamental toxicological sciences

Orally administered &lt;i&gt;p&lt;/i&gt;-nitrotoluene causes hyperactivity, concomitant with gliosis and impairment of tyrosine hydroxylase immunoreactivity in the rat substantia nigra